Enhancing Clinical Trials With CliniPilot And Clear To Clinic Programme

Clinical trial sponsors face increasing pressure to accelerate development while maintaining data integrity, regulatory compliance, and patient engagement. Connected drug delivery technologies and clinic-ready device platforms are emerging as powerful tools to address these challenges by reducing operational complexity and enabling more efficient trial execution.

In this interview, experts from Ypsomed discuss how digital connectivity and pre-qualified autoinjector platforms are transforming clinical development. The conversation highlights how automated injection data capture can improve data quality, reduce the burden of manual documentation, and provide real-time insights into patient adherence and behavior. It also explores strategies for eliminating common development bottlenecks, including pharmacokinetic bridging studies that can delay timelines and increase costs.

By combining clinic-ready devices with connected technologies, sponsors can support decentralized and hybrid trial models, simplify regulatory submissions, and improve the patient experience. The discussion also examines the long-term value of real-world injection data and how digital health solutions may shape future clinical and commercial programs.